130 results
Page 5 of 7
6-K
EX-99.2
pdy21fvetv3
11 Aug 20
Management’s Discussion and Analysis of Financial Condition and Results of
12:00am
6-K
EX-99.1
x58qbya0r8s6fpbp3vv9
11 Aug 20
Management’s Discussion and Analysis of Financial Condition and Results of
12:00am
6-K
EX-99.3
1hcor1lvte82mvxsuzm
3 Aug 20
Current report (foreign)
9:45pm
6-K
EX-99.2
95g88t7kcxfl
3 Aug 20
Current report (foreign)
9:45pm
SUPPL
g2syri5onjweh13ts8
31 Jul 20
Supplemental materials (foreign)
9:43pm
6-K
EX-99.1
9h93q32s 1iwzodzl8ro
13 Jul 20
Current report (foreign)
12:00am
SUPPL
gwqjxj3
13 Jul 20
Supplemental materials (foreign)
12:00am
F-10/A
oowcg5q tfg
16 Jun 20
Registration of securities (Canada) (amended)
9:20pm
F-10/A
EX-5.2
owckcl1n8xe
16 Jun 20
Registration of securities (Canada) (amended)
9:20pm
F-10/A
EX-7.1
e6y3bln2b2no79
16 Jun 20
Registration of securities (Canada) (amended)
9:20pm
F-10/A
EX-5.1
tb0n85k66 48zhax
16 Jun 20
Registration of securities (Canada) (amended)
9:20pm
6-K
EX-99.1
09gg5cmska xcj7y
16 Jun 20
Material Change Report
12:00am
6-K
EX-99.1
o6yx8rdcmsxbq
3 Jun 20
FSD Pharma Receives U.S. FDA Approval to design a Phase 2a Clinical Trial to Treat Patients with Suspected or Confirmed COVID-19 Diagnosis
10:41am
6-K
EX-99.1
enqfewms5h xze
15 May 20
Management’s Discussion and Analysis of Financial Condition and Results of
10:48am
6-K
EX-99.2
v5ocibk2 bup
15 May 20
Management’s Discussion and Analysis of Financial Condition and Results of
10:48am
40-F/A
EX-99.2
ke0q0jv0rmktzetrg1
17 Mar 20
Annual report (Canada) (amended)
5:14pm
40-F/A
EX-99.9
s2zinm7glu1j0
17 Mar 20
Annual report (Canada) (amended)
5:14pm
40-F/A
EX-99.10
4ztkwp cnt
17 Mar 20
Annual report (Canada) (amended)
5:14pm
40-F
EX-99.10
y1nbf1oxnoi k0
4 Mar 20
Annual report (Canada)
12:29pm
40-F
EX-99.1
ozk2fyuc5n9s wpx
4 Mar 20
Annual report (Canada)
12:29pm